Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
NASDAQ:DXCM
Price:
127.2 USD
-0.15%
Updated:
May 1, 2024
P/E
Price to Earnings
Price to Earnings
90.5
Current
119.5
Median
23.2
Industry
Lower
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=90.5
Market Cap
/
49B
Net Income
541.5m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49B USD | 90.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
185B USD | 32.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.2B USD | 66.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.9B USD | 39.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108B USD | 25.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 67.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 55.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 38.3 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 32.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.7B USD | 36.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
38.9B USD | 46.2 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
71.3
2-Years Forward
P/E
55.9
3-Years Forward
P/E
44.9
You don't have any saved screeners yet
